1. Home
  2. LBRDP vs CMMB Comparison

LBRDP vs CMMB Comparison

Compare LBRDP & CMMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LBRDP
  • CMMB
  • Stock Information
  • Founded
  • LBRDP N/A
  • CMMB 2004
  • Country
  • LBRDP United States
  • CMMB Israel
  • Employees
  • LBRDP 1900
  • CMMB N/A
  • Industry
  • LBRDP Cable & Other Pay Television Services
  • CMMB Biotechnology: Pharmaceutical Preparations
  • Sector
  • LBRDP Telecommunications
  • CMMB Health Care
  • Exchange
  • LBRDP Nasdaq
  • CMMB Nasdaq
  • Market Cap
  • LBRDP N/A
  • CMMB 37.3M
  • IPO Year
  • LBRDP N/A
  • CMMB N/A
  • Fundamental
  • Price
  • LBRDP $24.99
  • CMMB $1.97
  • Analyst Decision
  • LBRDP
  • CMMB Strong Buy
  • Analyst Count
  • LBRDP 0
  • CMMB 2
  • Target Price
  • LBRDP N/A
  • CMMB $7.50
  • AVG Volume (30 Days)
  • LBRDP N/A
  • CMMB 82.4K
  • Earning Date
  • LBRDP N/A
  • CMMB 03-06-2025
  • Dividend Yield
  • LBRDP N/A
  • CMMB N/A
  • EPS Growth
  • LBRDP N/A
  • CMMB N/A
  • EPS
  • LBRDP N/A
  • CMMB N/A
  • Revenue
  • LBRDP N/A
  • CMMB N/A
  • Revenue This Year
  • LBRDP N/A
  • CMMB N/A
  • Revenue Next Year
  • LBRDP N/A
  • CMMB N/A
  • P/E Ratio
  • LBRDP N/A
  • CMMB N/A
  • Revenue Growth
  • LBRDP N/A
  • CMMB N/A
  • 52 Week Low
  • LBRDP N/A
  • CMMB $0.55
  • 52 Week High
  • LBRDP N/A
  • CMMB $2.55
  • Technical
  • Relative Strength Index (RSI)
  • LBRDP 45.96
  • CMMB 56.98
  • Support Level
  • LBRDP $24.94
  • CMMB $2.02
  • Resistance Level
  • LBRDP $25.50
  • CMMB $2.15
  • Average True Range (ATR)
  • LBRDP 0.56
  • CMMB 0.12
  • MACD
  • LBRDP -0.07
  • CMMB -0.01
  • Stochastic Oscillator
  • LBRDP 13.03
  • CMMB 69.57

About LBRDP Liberty Broadband Corporation Series A Cumulative Redeemable Preferred Stock

Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential and small to medium businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.

About CMMB Chemomab Therapeutics Ltd.

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Share on Social Networks: